Equivocal cytology in lung cancer diagnosis

Cancer Cytopathology

Volumn 119, Issue 3, 2011, Pages 177-192

  Schramm, Martin ^a   Wrobel, Christian ^a   Born, Ingmar ^a   Kazimirek, Marietta ^a   Pomjanski, Natalia ^a   William, Marina ^a   Kappes, Rainer ^b   Gerharz, Claus Dieter ^c   Biesterfeld, Stefan ^a   Bocking, Alfred ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b Florence Nightingale Hospital   (Germany)

^c Evangelical Bethesda Johanniter Clinical Center   (Germany)

Author keywords

Cytology; DNA image cytometry; FISH; Lung cancer; Promoter hypermethylation

Indexed keywords

APC PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; DNA;

ADULT; AGED; APC GENE; ARTICLE; CAMERA; CANCER CELL; CONTROLLED STUDY; CYTODIAGNOSIS; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; IMAGING SOFTWARE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MICROSCOPE; P16INK4A GENE; PRIORITY JOURNAL; PROMOTER REGION; RASSF1A GENE; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TRACHEOBRONCHIAL TOILET; TRANSBRONCHIAL ASPIRATION; TUMOR SUPPRESSOR GENE; COHORT ANALYSIS; GENETICS; LUNG TUMOR; METHODOLOGY; PATHOLOGY; STANDARD;

COHORT STUDIES; DNA METHYLATION; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; PROMOTER REGIONS, GENETIC; REFERENCE STANDARDS;

EID: 80051628360     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20142     Document Type: Article

References (60)

1. American Cancer Society. Cancer Facts and Figures 2008. Atlanta, Georgia: American Cancer Society; 2008.
2. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765-781.
3. Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009.
4. International Early Lung Cancer Action Program Investigators, Henschke CI, Yankelevitz DF, Libby DM, Pasmantier MW, Smith JP, Miettinen OS. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763-1771.
5. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: Summary of published evidence. Chest. 2003;123(suppl 1): 115S-128S.
6. Rivera MP, Mehta AC. Initial diagnosis of lung cancer: ACCP Evidence-Based Clinical Practice Guidelines, 2nd ed. Chest. 2007;132:131S-148S
7. Naryshkin S, Young NA. Respiratory cytology: A review of non-neoplastic mimics of malignancy. Diagn Cytopathol. 1993;9:89-97.
8. Silverman JF. Inflammatory and neoplastic processes of the lung: Differential diagnosis and pitfalls in FNA biopsies. Diagn Cytopathol. 1995;13:448-462.
9. Crapanzano JP, Zakowski MF. Diagnostic dilemmas in pulmonary cytology. Cancer (Cancer Cytopathol). 2001;93: 364-375.
10. Koss LG, Melamed MR. Tumours of the lung: Conventional cytology and aspiration biopsy. In: Koss LG, Melamed MR, eds. Koss' Diagnostic Cytology And Its Histopathologic Bases. Volumes I and II. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:643-712.
11. Savic S, Glatz K, Schoenegg R, et al. Multitarget fluorescence in situ hybridisation elucidates equivocal lung cytology. Chest. 2006;129:1629-1635.
12. Glatz K, Savic S, Glatz D, et al. An online quiz uncovers limitations of morphology in equivocal lung cytology. Cancer (Cancer Cytopathol). 2006;108:480-487.
13. Torres EM, Williams BR, Amon A. Aneuploidy: Cells losing their balance. Genetics. 2008;179:737-746.
14. Williams BR, Prabhu VR, Hunter KE, et al. Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science. 2008;322:703-709.
15. Duesberg P. Chromosomal chaos and cancer. Sci Am. 2007; 296:52-59.
16. Fabarius A, Li R, Yerganian G, Hehlmann R, Duesberg P. Specific clones of spontaneously evolving karyotypes generate individuality of cancers. Cancer Genet Cytogenet. 2008; 180:89-99.
17. Li L, McCormack AA, Nicholson JM, et al. Cancer-causing karyotypes: Chromosomal equilibria between destabilizing aneuploidy and stabilizing selection for oncogenic function. Cancer Genet Cytogenet. 2009;188:1-25.
18. Sokolova IA, Bubendorf L, O'Hare A, et al. A fluorescence in situ hybridization-based assay for improved detection of lung cancer cells in bronchial washing specimens. Cancer (Cancer Cytopathol). 2002;96:306-315.
19. Varella-Garcia M, Kittelson J, Schulte AP, et al. Multi-target interphase fluoresence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detect Prev. 2004;28:244-251.
20. Varella-Garcia M, Schulte AP, Wolf HJ, et al. The detection of chromosomal aneusomy by fluorescence in situ hybridization in sputum predicts lung cancer incidence. Cancer Prev Res. 2010;3:447-453.
21. Bubendorf L, Muller P, Joos L, et al. Multitarget FISH analysis in the diagnosis of lung cancer. Am J Clin Pathol. 2005;123:516-523.
22. Halling KC, Rickman OB, Kipp BR, Harwood AR, Doerr CH, Jett Jr. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens. Chest. 2006;130:694-701.
23. Kettunen E, Salmenkivi K, Vuopala K, et al. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer. Lung Cancer. 2006;54:169-176.
24. Kang JU, Koo SH, Kwon KC, Park JW, Jung SS. Gain of the EGFR gene located on 7p12 is a frequent and early event in squamous cell carcinoma of the lung. Cancer Genet Cytogenet. 2008;184:31-37.
25. Zudaire I, Lozano MD, Vazquez MF, et al. Molecular characterization of small peripheral lung tumors based on the analysis of fine needle aspirates. Histol Histopathol. 2008;23:33-40.
26. Voss JS, Kipp BR, Halling KC, et al. Fluorescence in situ hybridization testing algorithm improves lung cancer detection in bronchial brushing specimens. Am J Respir Crit Care Med. 2010;181:478-485.
27. Chatelain R, Willms A, Biesterfeld S, Auffermann W, Bocking A. Automated Feulgen staining with a temperature controlled staining machine. Anal Quant Cytol Histol. 1989; 11:211-217.
28. Bocking A. DNA measurements. When and why? In: Wied GL, Keebler CM, Rosenthal DL, et al, eds. Compendium on Quality Assurance, Proficiency Testing, and Workload Limitations. Chicago, IL: Tutorials of Cytology; 1995:170-188.
29. Nasiell M, Kato H, Auer G, Zetterberg A, Roger V, Karlen L. Cytomorphological grading and Feulgen DNA-analysis of metaplastic and neoplastic bronchial cells. Cancer. 1978; 41:1511-1521.
30. Ono J, Auer G. The significance of DNA measurements for the early detection of bronchial cell atypia. Cytometry. 1983;3:340-344.
31. Pak HY, Teplitz RL, Ashdjian V, Yokota SB, Hammond WG, Benfield Jr. Quantitative DNA determination by image analysis. II. Application to human and canine pulmonary cytology. Anal Quant Cytol. 1983;5:263-268.
32. Auffermann W, Bocking A. Early detection of precancerous lesions in dysplasias of the lung by rapid DNA-image cytometry. Anal Quant Cytol Histol. 1985;7:218-226.
33. Carey FA, Gray E, O'Mahony M, Craig SR, Salto-Tellez M, Lamb D. A comparison of flow and image DNA cytometry in prediction of patient prognosis in surgically resected small cell lung cancer. Anal Cell Pathol. 1996;12: 137-143.
34. Maounis NF, Chorti M, Apostolakis E, et al. Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers. Cancer Detect Prev. 2006;30:507-514.
35. Petersen I, Kotb WF, Friedrich KH, Schluns K, Bocking A, Dietel M. Core classification of lung cancer: Correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer. 2009;65:312-318.
36. Merlo A, Herman JG, Mao L, et al. 50 CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med. 1995;1:686-692.
37. Belinsky SA. Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Cancer. 2004;4:707-717.
38. Belinsky SA. Silencing of genes by promoter hypermethylation: key event in rodent and human lung cancer. Carcinogenesis. 2005;26:1481-1487.
39. Duffy MJ, Napieralski R, Martens JW, et al; on behalf of the EORTC PathoBiology Group l. Methylated genes as new cancer biomarkers. Eur J Cancer. 2009;45:335-346.
40. Schmiemann V, Bocking A, Kazimirek M, et al. Methylation assay for the diagnosis of lung cancer on bronchial aspirates: A cohort study. Clin Cancer Res. 2005;11:7728-7734.
41. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000;60:5954-5958.
42. Belinsky SA, Liechty KC, Gentry FD, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res. 2006; 66:3338-3344.
43. Onofre FB, Onofre AS, Pomjanski N, Buckstegge B, Grote HJ, Bocking A. Deletion in the diagnosis of malignant mesothelioma in serous effusions additional to immunocytochemistry, DNA-ICM, and AgNOR analysis. Cancer (Cancer Cytopathol). 2008;114:204-215.
44. Hamada S, Namura K, Fujita S, Kushima R, Hattori T. DNA ploidy and proliferative activity of human pulmonary epithelium. Virchows Arch B Cell Pathol Incl Mol Pathol. 1990;58:405-410.
45. Bocking A, Giroud F, Reith A. Consensus report of the ESACP task force on standardization of diagnostic DNA-image cytometry. Anal Cell Pathol. 1995;8:67-74.
46. Giroud F, Haroske G, Reith A, Bocking A. 1997 ESACP consensus report on diagnostic DNA-image cytometry. pt II: Specific recommendations for quality assurance. Anal Cell Pathol. 1998;17:201-207.
47. Haroske G, Giroud F, Reith A, Bocking A. 1997 ESACP consensus report on diagnostic DNA-image cytometry. pt I: Basic considerations and recommendations for preparation, measurement and interpretation. Anal Cell Pathol. 1998;17: 189-200.
48. Haroske G, Baak JP, Danielsen H, et al. Fourth updated ESACP consensus report on diagnostic DNA-image cytometry. Anal Cell Pathol. 2001;23:89-95.
49. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A. 1996;93:9821-9826.
50. Grote HJ, Schmiemann V, Kiel S, et al. Aberrant methylation of the adenomatous polyposis coli promoter 1 A in bronchial aspirates from patients with suspected lung cancer. Int J Cancer. 2004;110:751-755.
51. Bossuyt PM, Reitsma JB, Bruns DE, et al Standards for Reporting of Diagnostic Accuracy. Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative. BMJ. 2003;326:41-44.
52. Zimmet J, Ravid K. Polyploidy: Occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system. Exp Hematol. 2000;28:3-16.
53. Sandritter W, Adler CP. Polyploidization of heart muscle nuclei as a prerequisite for heart growth and numerical hyperplasia in heart hypertrophy. Recent Adv Stud Cardiac Struct Metab. 1976;12:115-127.
54. Saccomanno G. Diagnostic Pulmonary Cytology. 2nd ed. Chicago, IL: American Society of Clinical Pathologists Press; 1986:42-44.
55. Bassermann FJ. Polyploidy, endomitosis & double nucleation in ciliated cells of the bronchial epithelium in man. Thoraxchirurgie. 1957;4:464-470.
56. Biesterfeld S, Fuzesi L, Harle F, Bocking A. DNA-cytometric detection of euploid polyploidization in oral lichen ruber planus. Anal Quant Cytol Histol. 1991;13:7-10.
57. Biesterfeld S, Gerres K, Fischer-Wein G, Bocking A. Polyploidy in non-neoplastic tissues. J Clin Pathol. 1994;47: 38-42.
58. Brabender J, Usadel H, Danenberg KD, et al. Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene. 2001;20:3528-3532.
59. Waki T, Tamura G, Sato M, Motoyama T. Age-related methylation of tumor suppressor and tumor-related genes: An analysis of autopsy samples. Oncogene. 2003;22:4128-4133.
60. Bundesministerium der Justiz: Gebuhrenordnung fur Arzte in der Fassung der Bekanntmachung vom 9. Februar 1996. Bundesgesetzblatt I:210, Anderung durch Artikel 17 des Gesetzes vom 4. Dezember 2001. Bundesgesetzblatt I:3320.